nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
A call to action for equitable care for trans and non-binary people
|
Connolly, Dean J |
|
|
403 |
10422 |
p. 139-140 |
artikel |
2 |
All children pay the price for antisemitic bias
|
Adler, Nikki R |
|
|
403 |
10422 |
p. 143-144 |
artikel |
3 |
Brazil to start widespread dengue vaccinations
|
Alves, Lise |
|
|
403 |
10422 |
p. 133 |
artikel |
4 |
Chagas disease
|
de Sousa, Andréa Silvestre |
|
|
403 |
10422 |
p. 203-218 |
artikel |
5 |
Comparative efficacy of ligelizumab versus omalizumab in chronic spontaneous urticaria
|
Moussa, Sarah |
|
|
403 |
10422 |
p. 118-119 |
artikel |
6 |
Coronary embolisation of native aortic valve debris during transcatheter aortic valve replacement: mechanical embolectomy and histopathological analysis
|
Landi, Antonio |
|
|
403 |
10422 |
p. e5-e6 |
artikel |
7 |
Daring to dream: a message of hope and togetherness
|
Nacer, Hadjer |
|
|
403 |
10422 |
p. 136 |
artikel |
8 |
Department of Error
|
|
|
|
403 |
10422 |
p. 146 |
artikel |
9 |
Department of Error
|
|
|
|
403 |
10422 |
p. 146 |
artikel |
10 |
Department of Error
|
|
|
|
403 |
10422 |
p. 146 |
artikel |
11 |
Donald Bernard Longmore
|
Watts, Geoff |
|
|
403 |
10422 |
p. 138 |
artikel |
12 |
Efficacy and safety of ligelizumab in adults and adolescents with chronic spontaneous urticaria: results of two phase 3 randomised controlled trials
|
Maurer, Marcus |
|
|
403 |
10422 |
p. 147-159 |
artikel |
13 |
Efficacy and safety of the muscarinic receptor agonist KarXT (xanomeline–trospium) in schizophrenia (EMERGENT-2) in the USA: results from a randomised, double-blind, placebo-controlled, flexible-dose phase 3 trial
|
Kaul, Inder |
|
|
403 |
10422 |
p. 160-170 |
artikel |
14 |
End-of-life, participatory democracy, and legislative work in France
|
Delfraissy, Jean-François |
|
|
403 |
10422 |
p. 141 |
artikel |
15 |
French political bargaining over undocumented migrants’ health
|
Cailhol, Johann |
|
|
403 |
10422 |
p. 140-141 |
artikel |
16 |
Innocence and experience
|
Boyce, Niall |
|
|
403 |
10422 |
p. 135 |
artikel |
17 |
Interpreting COVID-19 data from China: a call for caution
|
Qu, Zhi |
|
|
403 |
10422 |
p. 144 |
artikel |
18 |
Interpreting COVID-19 data from China: a call for caution – Authors' reply
|
Wang, Liang |
|
|
403 |
10422 |
p. 144-145 |
artikel |
19 |
Is neutrality superior to humanity?
|
Sprung, Charles |
|
|
403 |
10422 |
p. 142-143 |
artikel |
20 |
Israel and Gaza: a quick end to a tragic but necessary war
|
Teitel, Jerome |
|
|
403 |
10422 |
p. 143 |
artikel |
21 |
Millions face food insecurity as WFP scales back in Syria
|
Samarasekera, Udani |
|
|
403 |
10422 |
p. 132 |
artikel |
22 |
Moving cholera vaccines ahead of the epidemic curve
|
Memish, Ziad A |
|
|
403 |
10422 |
p. 127-129 |
artikel |
23 |
Multiple sclerosis
|
Jakimovski, Dejan |
|
|
403 |
10422 |
p. 183-202 |
artikel |
24 |
Muscarinic drug shows efficacy in schizophrenia but much is left to be discovered
|
Cipriani, Andrea |
|
|
403 |
10422 |
p. 120-122 |
artikel |
25 |
NGOs warn over health and wellbeing in Angkor Wat
|
Tatum, Megan |
|
|
403 |
10422 |
p. 130-131 |
artikel |
26 |
Peter Hotez: physician-scientist-warrior combating anti-science
|
Samarasekera, Udani |
|
|
403 |
10422 |
p. 134 |
artikel |
27 |
Profit over people: the injustice of commercial determinants of health
|
Khajuria, Ankur |
|
|
403 |
10422 |
p. 141-142 |
artikel |
28 |
SBRT for oligoprogressive disease: using the evidence to maximise the benefits
|
Hanna, Gerard G |
|
|
403 |
10422 |
p. 122-124 |
artikel |
29 |
Sotorasib in KRASG12C mutated lung cancer
|
Olivier, Timothée |
|
|
403 |
10422 |
p. 145 |
artikel |
30 |
Sotorasib in KRASG12C mutated lung cancer – Authors' reply
|
Paz-Ares, Luis |
|
|
403 |
10422 |
p. 145-146 |
artikel |
31 |
Standard-of-care systemic therapy with or without stereotactic body radiotherapy in patients with oligoprogressive breast cancer or non-small-cell lung cancer (Consolidative Use of Radiotherapy to Block [CURB] oligoprogression): an open-label, randomised, controlled, phase 2 study
|
Tsai, Chiaojung Jillian |
|
|
403 |
10422 |
p. 171-182 |
artikel |
32 |
Tawhida Ben Cheikh: champion of women's health in Tunisia
|
Ferry, Georgina |
|
|
403 |
10422 |
p. 137 |
artikel |
33 |
The future of the global clinical trial ecosystem: a vision from the first WHO Global Clinical Trials Forum
|
Moorthy, Vasee |
|
|
403 |
10422 |
p. 124-126 |
artikel |
34 |
Time for renewed optimism for schizophrenia?
|
The Lancet, |
|
|
403 |
10422 |
p. 117 |
artikel |
35 |
Transferable exclusivity voucher: a flawed incentive to stimulate antibiotic innovation
|
Årdal, Christine |
|
|
403 |
10422 |
p. e2-e4 |
artikel |